| 1 |
Lazarevic I, Banko A, Miljanovic D, Cupic M. Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas. Viruses 2023;15:373. [DOI: 10.3390/v15020373] [Reference Citation Analysis]
|
| 2 |
Huang YS, Sun HY, Chang SY, Chuang YC, Su YC, Liu WC, Hung CC. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus. Int J Antimicrob Agents 2022;60:106682. [PMID: 36279976 DOI: 10.1016/j.ijantimicag.2022.106682] [Reference Citation Analysis]
|
| 3 |
Zhou F, Xiong H, Zhen S, Chen A, Huang M, Luo Y. Serum levels of IL-12, IL-18, and IL-21 are indicators of viral load in patients chronically infected with HBV. Braz J Med Biol Res 2022;55. [DOI: 10.1590/1414-431x2022e12320] [Reference Citation Analysis]
|
| 4 |
Luo W, Xin H, Zhao P, Jiang S. Effects of HBeAg Status on cellular immune function of patients with Hepatitis B virus/Treponema Pallidum Co-infectio. Pak J Med Sci 2021;37:1871-6. [PMID: 34912410 DOI: 10.12669/pjms.37.7.4253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Akbar SMF, Al Mahtab M, Cesar Aguilar J, Uddin MH, Khan MSI, Yoshida O, Penton E, Gerardo GN, Hiasa Y. Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical. Exploration of Medicine. [DOI: 10.37349/emed.2021.00058] [Reference Citation Analysis]
|
| 6 |
Zhou JY, Song LW, Yuan R, Lu XP, Wang GQ. Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm. World J Gastroenterol 2021; 27(21): 2910-2920 [PMID: 34135561 DOI: 10.3748/wjg.v27.i21.2910] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Yang H, Chen C. Epidemiology and Natural History of Hepatitis B Virus Infection: Time-Dependent Driving Factors of Chronic Hepatitis B Progression. Hepatitis B Virus and Liver Disease 2021. [DOI: 10.1007/978-981-16-3615-8_7] [Reference Citation Analysis]
|
| 8 |
Nicastro E, Mangili B, Giacomet V, Benincaso AR, Di Giorgio A, Sansotta N, Callegaro A, D'Antiga L. Longitudinal Immune Phenotype Assessment and Serological Outcome in Foreign-born Children With Chronic Hepatitis B. J Pediatr Gastroenterol Nutr 2020;71:381-7. [PMID: 32826716 DOI: 10.1097/MPG.0000000000002804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Ma Z, Zhang E, Gao S, Xiong Y, Lu M. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response. Front Immunol 2019;10:2308. [PMID: 31608073 DOI: 10.3389/fimmu.2019.02308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
